We are live on ! Find out more
NERV icon

Minerva Neurosciences

72 hedge funds and large institutions have $93M invested in Minerva Neurosciences in 2021 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 26 increasing their positions, 23 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

225% more capital inflows, than outflows

Capital inflows: $9.36M | Capital outflows: $2.88M

124% more call options, than puts

Call options by funds: $755K | Put options by funds: $337K

13% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 23

4.61% more ownership

Funds ownership: 68.92% → 73.53% (+4.6%)

5% less funds holding

Funds holding: 76 → 72 (-4)

44% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 9

Holders
72
Holders Change
-4
Holders Change %
-5.26%
% of All Funds
1.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
26
Reduced
23
Closed
9
Calls
$755​K
Puts
$337​K
Net Calls
+$418​K
Net Calls Change
+$383​K

NERV Hedge Fund Activity: Q1 2021 in Review

72 of the 5,715 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q1 2021, worth a combined $93M — up 32% from $70.2M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of NERV and 5 opened new positions — a net loss of 4 holders — while 23 trimmed existing stakes and 26 added.

The largest buyer was Wells Fargo, adding an estimated $1.55M. The largest seller was Renaissance Technologies, cutting an estimated $772K.

  • 72 institutional investors held Minerva Neurosciences (NERV) as of Q1 2021, down from 76 in Q4 2020.
  • Funds reported $93M of Minerva Neurosciences stock for Q1 2021, up 32% quarter-over-quarter.
  • 5 funds opened new Minerva Neurosciences positions in Q1 2021 and 9 closed out, a net change of -4 holders.
  • The largest Minerva Neurosciences buyer in Q1 2021 was Wells Fargo, an estimated $1.55M added.
  • The largest Minerva Neurosciences seller in Q1 2021 was Renaissance Technologies, an estimated $772K sold.

Based on aggregated 13F filings for Q1 2021.